These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 18334756)
21. Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Krasuski JS; Alexander GE; Horwitz B; Daly EM; Murphy DG; Rapoport SI; Schapiro MB Biol Psychiatry; 1998 Jan; 43(1):60-8. PubMed ID: 9442345 [TBL] [Abstract][Full Text] [Related]
22. A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: magnetic resonance imaging volumetric study. Barber R; McKeith IG; Ballard C; Gholkar A; O'Brien JT Dement Geriatr Cogn Disord; 2001; 12(3):198-205. PubMed ID: 11244213 [TBL] [Abstract][Full Text] [Related]
23. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Schuff N; Capizzano AA; Du AT; Amend DL; O'Neill J; Norman D; Kramer J; Jagust W; Miller B; Wolkowitz OM; Yaffe K; Weiner MW Neurology; 2002 Mar; 58(6):928-35. PubMed ID: 11914410 [TBL] [Abstract][Full Text] [Related]
24. MRI for iron mapping in Alzheimer's disease. Langkammer C; Ropele S; Pirpamer L; Fazekas F; Schmidt R Neurodegener Dis; 2014; 13(2-3):189-91. PubMed ID: 23942230 [TBL] [Abstract][Full Text] [Related]
25. Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease. Matsumoto Y; Yanase D; Noguchi-Shinohara M; Ono K; Yoshita M; Yamada M Dement Geriatr Cogn Disord; 2007; 23(4):241-5. PubMed ID: 17310121 [TBL] [Abstract][Full Text] [Related]
26. Medial temporal atrophy as a magnetic resonance imaging marker for Alzheimer's disease. Barclay LL; Linden C; Murtagh R J Neuroimaging; 1992 Jul; 2(3):131-5. PubMed ID: 10171577 [TBL] [Abstract][Full Text] [Related]
27. Cerebral changes and cerebrospinal fluid beta-amyloid in Alzheimer's disease: a study with quantitative magnetic resonance imaging. Schröder J; Pantel J; Ida N; Essig M; Hartmann T; Knopp MV; Schad LR; Sandbrink R; Sauer H; Masters CL; Beyreuther K Mol Psychiatry; 1997; 2(6):505-7. PubMed ID: 9399697 [TBL] [Abstract][Full Text] [Related]
28. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Killiany RJ; Moss MB; Albert MS; Sandor T; Tieman J; Jolesz F Arch Neurol; 1993 Sep; 50(9):949-54. PubMed ID: 8363449 [TBL] [Abstract][Full Text] [Related]
29. A new MRI ratio method for in-vivo estimation of signal hypointensity in aging and Alzheimer's disease. Parsey RV; Krishnan KR Prog Neuropsychopharmacol Biol Psychiatry; 1997 Nov; 21(8):1257-67. PubMed ID: 9460090 [TBL] [Abstract][Full Text] [Related]
30. Differential alterations of ion channel binding sites in temporal and occipital regions of the cerebral cortex in Alzheimer's disease. Ikeda M; Dewar D; McCulloch J Brain Res; 1993 Dec; 630(1-2):50-6. PubMed ID: 7509712 [TBL] [Abstract][Full Text] [Related]
32. Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Bartzokis G; Tishler TA; Shin IS; Lu PH; Cummings JL Ann N Y Acad Sci; 2004 Mar; 1012():224-36. PubMed ID: 15105269 [TBL] [Abstract][Full Text] [Related]
33. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Convit A; de Asis J; de Leon MJ; Tarshish CY; De Santi S; Rusinek H Neurobiol Aging; 2000; 21(1):19-26. PubMed ID: 10794844 [TBL] [Abstract][Full Text] [Related]
34. Temporal cortex synaptophysin mRNA is reduced in Alzheimer's disease and is negatively correlated with the severity of dementia. Heffernan JM; Eastwood SL; Nagy Z; Sanders MW; McDonald B; Harrison PJ Exp Neurol; 1998 Apr; 150(2):235-9. PubMed ID: 9527892 [TBL] [Abstract][Full Text] [Related]
35. Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET. Mosconi L; De Santi S; Li Y; Li J; Zhan J; Tsui WH; Boppana M; Pupi A; de Leon MJ Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):210-21. PubMed ID: 16311757 [TBL] [Abstract][Full Text] [Related]
36. Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease. Erkinjuntti T; Lee DH; Gao F; Steenhuis R; Eliasziw M; Fry R; Merskey H; Hachinski VC Arch Neurol; 1993 Mar; 50(3):305-10. PubMed ID: 8442711 [TBL] [Abstract][Full Text] [Related]
37. Laser ablation-inductively coupled plasma-mass spectrometry imaging of white and gray matter iron distribution in Alzheimer's disease frontal cortex. Hare DJ; Raven EP; Roberts BR; Bogeski M; Portbury SD; McLean CA; Masters CL; Connor JR; Bush AI; Crouch PJ; Doble PA Neuroimage; 2016 Aug; 137():124-131. PubMed ID: 27233149 [TBL] [Abstract][Full Text] [Related]
38. A spatial pattern analysis of beta-amyloid (Abeta) deposition in the temporal lobe in Alzheimer's disease. Armstrong RA Folia Neuropathol; 2010; 48(2):67-74. PubMed ID: 20602287 [TBL] [Abstract][Full Text] [Related]
39. Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. Quintana C; Bellefqih S; Laval JY; Guerquin-Kern JL; Wu TD; Avila J; Ferrer I; Arranz R; Patiño C J Struct Biol; 2006 Jan; 153(1):42-54. PubMed ID: 16364657 [TBL] [Abstract][Full Text] [Related]
40. Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease. Connor JR; Tucker P; Johnson M; Snyder B Neurosci Lett; 1993 Sep; 159(1-2):88-90. PubMed ID: 8264985 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]